A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to a Brazilian study reported in the Journal of Medical Virology.
Why Morgan Health is backing an autism care company
JP Morgan’s Morgan Health is rounding out its first three years of investing with its seventh investment. The health venture, which the … Sign up